Health Areas/Infectious Diseases & Post-Infectious Illness (Human)

Infectious Diseases & Post-Infectious Illness (Human)

First synthesised Jun 9, 2026·Last reviewed Jun 9, 2026

Infections and the chronic illnesses that follow them. Covers acute and chronic viral infections (COVID-19, HIV, EBV, herpesviruses, hepatitis), bacterial infections with chronic-illness potential (Lyme disease, syphilis, tuberculosis), and the post-infectious syndromes that share mechanisms across them (Long COVID, ME/CFS, post-viral chronic fatigue, latent virus reactivation patterns). Many of these conditions involve inflammation, immune dysregulation, autonomic dysfunction, and mitochondrial dysfunction, but the patient mental model is infection-origin: 'I have COVID', 'I have Lyme', 'I have HIV', not 'I have inflammation'. This Health Area groups them by what a patient would actually search for, while preserving the cross-cutting mechanism connections through Cross_Topic_Connections.

This Health Area is currently being synthesized

We only publish a complete Health Area once we’ve analysed enough expert discussions to produce a trustworthy synthesis you can rely on.

Current progress
We’ve identified the first topics that belong to this Health Area.
What’s next
We’re analysing more expert discussions and expanding topic coverage until consistent biological patterns emerge and the first Health Path can be synthesised.
Why this matters
You get guidance grounded in a large body of expert knowledge, not isolated opinions or premature conclusions.
Suggest an expert discussion

Know an outstanding podcast or expert discussion about Infectious Diseases & Post-Infectious Illness? We’d be happy to review it.

Every recommendation is independently reviewed before it becomes part of the synthesis.

research@toclarity.app

Topics already included in this Health Area

COVID-19 & Long COVID (Human)
Acute COVID-19 and Long COVID effects, with particular focus on multi-organ chronic disease patterns that persist after the acute infection clears. Covers Long COVID research from large-scale epidemiology (VA electronic health records), the diabetes-after-COVID link, cumulative re-infection risk, post-viral chronic illness frameworks, and the gap between mainstream research consensus and politicized public discourse. Opens the Human COVID side of the toClarity catalog. Topic is Class B contested-tier YMYL: the research itself is mainstream-anchored (Nature, NEJM, JAMA), but politicization of the pandemic means findings face contested public framing. Initial content focuses on the Long COVID dimension where the strongest research evidence exists. · 11 episodes
ME/CFS (Human)
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome. A complex multi-system illness whose leading symptom is Post-Exertional Malaise (PEM) — a worsening of all symptoms hours to days after physical or cognitive exertion. Can arise after viral infections (most prominently COVID-19) and shares mechanism with severe Long COVID. No definitive biomarker exists yet; diagnosis is symptom-criteria-based using catalogues like the Canadian Consensus Criteria, IOM, or International Consensus Criteria for ME. · 6 episodes